US pharmaceutical giants trialing 'exciting' experimental melanoma drug

Australian Personalised mRNA Cancer Immunotherapy Hub Head associate professor Seth Cheetham joined Ross Stevenson and Russel Howcroft to discuss an experimental melanoma drug that delivers treatment tailored to a patient's specific tumour which has prevented the deadly form of skin cancer from returning in a large clinical trial by US pharmaceutical giants Merck and Moderna. See…